363 related articles for article (PubMed ID: 29957488)
41. Stochastic properties of processive cytidine DNA deaminases AID and APOBEC3G.
Chelico L; Pham P; Goodman MF
Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):583-93. PubMed ID: 19022738
[TBL] [Abstract][Full Text] [Related]
42. Replication protein A (RPA) hampers the processive action of APOBEC3G cytosine deaminase on single-stranded DNA.
Lada AG; Waisertreiger IS; Grabow CE; Prakash A; Borgstahl GE; Rogozin IB; Pavlov YI
PLoS One; 2011; 6(9):e24848. PubMed ID: 21935481
[TBL] [Abstract][Full Text] [Related]
43. The cytidine deaminase AID exhibits similar functional properties in yeast and mammals.
Rogozin IB; Pavlov YI
Mol Immunol; 2006 Mar; 43(9):1481-4. PubMed ID: 16219354
[TBL] [Abstract][Full Text] [Related]
44. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
[TBL] [Abstract][Full Text] [Related]
45. Diverse functions for DNA and RNA editing in the immune system.
Hamilton CE; Papavasiliou FN; Rosenberg BR
RNA Biol; 2010; 7(2):220-8. PubMed ID: 20220309
[TBL] [Abstract][Full Text] [Related]
46. The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain.
Haché G; Liddament MT; Harris RS
J Biol Chem; 2005 Mar; 280(12):10920-4. PubMed ID: 15647250
[TBL] [Abstract][Full Text] [Related]
47. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
48. Advantages and disadvantages of cytidine deamination.
Cascalho M
J Immunol; 2004 Jun; 172(11):6513-8. PubMed ID: 15153462
[TBL] [Abstract][Full Text] [Related]
49. APOBEC3A is a prominent cytidine deaminase in breast cancer.
Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
[TBL] [Abstract][Full Text] [Related]
50. Active RNAP pre-initiation sites are highly mutated by cytidine deaminases in yeast, with AID targeting small RNA genes.
Taylor BJ; Wu YL; Rada C
Elife; 2014 Sep; 3():e03553. PubMed ID: 25237741
[TBL] [Abstract][Full Text] [Related]
51. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1.
Xie K; Sowden MP; Dance GS; Torelli AT; Smith HC; Wedekind JE
Proc Natl Acad Sci U S A; 2004 May; 101(21):8114-9. PubMed ID: 15148397
[TBL] [Abstract][Full Text] [Related]
52. AID Recognizes Structured DNA for Class Switch Recombination.
Qiao Q; Wang L; Meng FL; Hwang JK; Alt FW; Wu H
Mol Cell; 2017 Aug; 67(3):361-373.e4. PubMed ID: 28757211
[TBL] [Abstract][Full Text] [Related]
53. Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.
Love RP; Xu H; Chelico L
J Biol Chem; 2012 Aug; 287(36):30812-22. PubMed ID: 22822074
[TBL] [Abstract][Full Text] [Related]
54. Balancing AID and DNA repair during somatic hypermutation.
Liu M; Schatz DG
Trends Immunol; 2009 Apr; 30(4):173-81. PubMed ID: 19303358
[TBL] [Abstract][Full Text] [Related]
55. Activation-induced deoxycytidine deaminase: Structural basis for favoring WRC hot motif specificities unique among APOBEC family members.
Pham P; Afif SA; Shimoda M; Maeda K; Sakaguchi N; Pedersen LC; Goodman MF
DNA Repair (Amst); 2017 Jun; 54():8-12. PubMed ID: 28388461
[No Abstract] [Full Text] [Related]
56. Nucleotide insertions and deletions complement point mutations to massively expand the diversity created by somatic hypermutation of antibodies.
Bowers PM; Verdino P; Wang Z; da Silva Correia J; Chhoa M; Macondray G; Do M; Neben TY; Horlick RA; Stanfield RL; Wilson IA; King DJ
J Biol Chem; 2014 Nov; 289(48):33557-67. PubMed ID: 25320089
[TBL] [Abstract][Full Text] [Related]
57. APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer.
Shi MJ; Meng XY; Lamy P; Banday AR; Yang J; Moreno-Vega A; Chen CL; Dyrskjøt L; Bernard-Pierrot I; Prokunina-Olsson L; Radvanyi F
Eur Urol; 2019 Jul; 76(1):9-13. PubMed ID: 30975452
[TBL] [Abstract][Full Text] [Related]
58. AID-RNA polymerase II transcription-dependent deamination of IgV DNA.
Pham P; Malik S; Mak C; Calabrese PC; Roeder RG; Goodman MF
Nucleic Acids Res; 2019 Nov; 47(20):10815-10829. PubMed ID: 31566237
[TBL] [Abstract][Full Text] [Related]
59. A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.
Kohli RM; Abrams SR; Gajula KS; Maul RW; Gearhart PJ; Stivers JT
J Biol Chem; 2009 Aug; 284(34):22898-904. PubMed ID: 19561087
[TBL] [Abstract][Full Text] [Related]
60. Characterization of Ig gene somatic hypermutation in the absence of activation-induced cytidine deaminase.
Longo NS; Satorius CL; Plebani A; Durandy A; Lipsky PE
J Immunol; 2008 Jul; 181(2):1299-306. PubMed ID: 18606684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
